DE60318610D1 - Pharmazeutische antidiabetes-zusammensetzung - Google Patents
Pharmazeutische antidiabetes-zusammensetzungInfo
- Publication number
- DE60318610D1 DE60318610D1 DE60318610T DE60318610T DE60318610D1 DE 60318610 D1 DE60318610 D1 DE 60318610D1 DE 60318610 T DE60318610 T DE 60318610T DE 60318610 T DE60318610 T DE 60318610T DE 60318610 D1 DE60318610 D1 DE 60318610D1
- Authority
- DE
- Germany
- Prior art keywords
- composition
- antidiabetes
- pharmaceutical
- insulin
- antlers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 abstract 1
- 230000003178 anti-diabetic effect Effects 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 210000003056 antler Anatomy 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2002127819 | 2002-10-17 | ||
| RU2002127819/14A RU2213568C1 (ru) | 2002-10-17 | 2002-10-17 | Фармацевтическая композиция и противодиабетическое средство на ее основе |
| PCT/RU2003/000219 WO2004035069A1 (fr) | 2002-10-17 | 2003-05-16 | Composition pharmaceutique antidiabetique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60318610D1 true DE60318610D1 (de) | 2008-02-21 |
| DE60318610T2 DE60318610T2 (de) | 2009-01-15 |
Family
ID=31989452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60318610T Expired - Lifetime DE60318610T2 (de) | 2002-10-17 | 2003-05-16 | Pharmazeutische antidiabetes-zusammensetzung |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20050170010A1 (de) |
| EP (1) | EP1561468B1 (de) |
| AT (1) | ATE383162T1 (de) |
| AU (1) | AU2003241994A1 (de) |
| CA (1) | CA2504747C (de) |
| DE (1) | DE60318610T2 (de) |
| RU (1) | RU2213568C1 (de) |
| WO (1) | WO2004035069A1 (de) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2054292C1 (ru) * | 1992-11-25 | 1996-02-20 | Сергей Николаевич Ларцев | Способ получения биологически активных веществ из пантов |
| RU2059411C1 (ru) * | 1992-11-25 | 1996-05-10 | Сергей Николаевич Ларцев | Способ получения биологически активных веществ из пантов |
| RU2077887C1 (ru) * | 1996-04-11 | 1997-04-27 | Владимир Владимирович Цыганков | Порошкообразный биогенный препарат из окостенелых оленьих рогов и пищевая добавка на его основе |
| CN1180567A (zh) * | 1996-10-21 | 1998-05-06 | 王堇屹 | 一种治疗糖尿病的药剂及其制备方法 |
| CN1284364A (zh) * | 2000-08-16 | 2001-02-21 | 仇景林 | 一种治疗糖尿病药品的生产方法 |
-
2002
- 2002-10-17 RU RU2002127819/14A patent/RU2213568C1/ru active
-
2003
- 2003-05-16 WO PCT/RU2003/000219 patent/WO2004035069A1/ru active IP Right Grant
- 2003-05-16 CA CA002504747A patent/CA2504747C/en not_active Expired - Lifetime
- 2003-05-16 AT AT03730945T patent/ATE383162T1/de not_active IP Right Cessation
- 2003-05-16 AU AU2003241994A patent/AU2003241994A1/en not_active Abandoned
- 2003-05-16 EP EP03730945A patent/EP1561468B1/de not_active Expired - Lifetime
- 2003-05-16 DE DE60318610T patent/DE60318610T2/de not_active Expired - Lifetime
-
2005
- 2005-04-14 US US10/907,749 patent/US20050170010A1/en not_active Abandoned
-
2006
- 2006-09-06 US US11/470,269 patent/US20070026088A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003241994A1 (en) | 2004-05-04 |
| EP1561468A1 (de) | 2005-08-10 |
| RU2213568C1 (ru) | 2003-10-10 |
| EP1561468B1 (de) | 2008-01-09 |
| ATE383162T1 (de) | 2008-01-15 |
| DE60318610T2 (de) | 2009-01-15 |
| CA2504747C (en) | 2009-10-13 |
| EP1561468A4 (de) | 2006-08-02 |
| CA2504747A1 (en) | 2004-04-29 |
| WO2004035069A1 (fr) | 2004-04-29 |
| US20070026088A1 (en) | 2007-02-01 |
| US20050170010A1 (en) | 2005-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003073917A3 (en) | Microdermabrasion fluid application system and method | |
| BR0314153B1 (pt) | "método de preparação de um material de tabaco com nìveis reduzidos de lignina e de compostos nitrogenados". | |
| ATE472955T1 (de) | Gesundheitskissen | |
| IS7043A (is) | Lyfjagjöf efnafræðilega umbreytts insúlíns í lungu | |
| SI1583562T1 (sl) | AngioPep-1, sorodne spojine in njihove uporabe | |
| PE20000560A1 (es) | Uso de peg-ifn-alfa y ribavirina para el tratamiento de hepatitis c cronica | |
| WO2005032336A3 (en) | Vertebroplasty device having a flexible plunger | |
| CY1110287T1 (el) | Χρηση της ανθρωπινης παραθυρεοειδους ορμονης | |
| AR037448A1 (es) | Composiciones para el tratamiento de semillas | |
| SG111967A1 (en) | An injectable pharmaceutical composition containing a non-steriodal anti-inflammatory drug and method for preparing the same | |
| DE60308959D1 (de) | Künstlicher Nagel und Verfahren zum Anbringen derselben | |
| SV2004001674A (es) | Conjugacion y proceso para la preparacion de una hormona monopegilatada terminalmente-n para una hormona para el crecimiento humano ref. 01449/1 | |
| IL173929A0 (en) | Analogues of kahalalide f and pharmaceutical compositions containing the same | |
| UY28154A1 (es) | Composiciones y metodos de cuidado oral | |
| PL350568A1 (en) | N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors | |
| AU2003272608A1 (en) | Modulating vesicular monoamine transporter trafficking and function: a novel approach for the treatment of parkinson's disease | |
| EP1454629A3 (de) | Insulinotrophe Substanz basierend auf Preproglucagon | |
| ATE383162T1 (de) | Pharmazeutische antidiabetes-zusammensetzung | |
| ITTO20020684A1 (it) | Nuovo uso dell'angelicina e di suoi analoghi strutturali. | |
| BR0213633A (pt) | Método e composto para tratar de uma doença associada com recrutamento e/ou ativação aberrante de leucócitos | |
| EP0820771A3 (de) | Arzneimittel zur Behandlung von Neuropathien, das ein lipidlösliches Thiamin und eine Magnesiumverbindung enthält | |
| BR9810387A (pt) | (s) 3, 4, 5-trimetoxibenzoato de 2-metilamino-2-fenil-n-butila, e sua aplicação para o tratamento de dor crÈnica | |
| AU2003230830A1 (en) | Treatment of type 1 diabetes before and after expression of predisposition markers | |
| ATE350038T1 (de) | Pharmazeutische zubereitungen enthaltend nanopartikel von 2-(4-ethoxy-phenyl)-3-(4- methansulphonyl-phenyl)-pyrazolo 1,5-böpyridazi | |
| PL370175A1 (en) | Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |